Shares of JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) rose 0.3% during trading on Monday . The stock traded as high as $3.33 and last traded at $3.33. Approximately 150 shares changed hands during mid-day trading, a decline of 61% from the average daily volume of 383 shares. The stock had previously closed at $3.32.
JCR Pharmaceuticals Stock Performance
The company’s 50 day moving average price is $3.27 and its 200-day moving average price is $3.77.
JCR Pharmaceuticals Company Profile
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Recommended Stories
- Five stocks we like better than JCR Pharmaceuticals
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
